EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia

Giuseppe Mario Bentivenga, Simone Baiardi iD, Andrea Mastrangelo, Corrado Zenesini, Angela Mammana, Marcello Rossi, Barbara Polischi, Sabina Capellari iD, Piero Parchi iD

International Journal of Molecular Sciences · 08.05.2024 · 25 (10) · 5106

DOI: 10.3390/ijms25105106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.05.2024. Verfasst von Giuseppe Mario Bentivenga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Neuromotor Sciences (DiBiNeM), University of Bologna, 40139 Bologna, Italy. Hauptthemen laut MEDLINE: Creutzfeldt-Jakob Syndrome, Glial Fibrillary Acidic Protein, tau Proteins, Biomarkers. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministero della Salute (“Ricerca Corrente”).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diagnostic and prognostic value of plasma glial fibrillary acidic protein (pl-GFAP) in sporadic Creutzfeldt–Jakob disease (sCJD) has never been assessed in the clinical setting of rapidly progressive dementia (RPD). Using commercially available immunoassays, we assayed the plasma levels of GFAP, tau (pl-tau), and neurofilament light chain (pl-NfL) and the CSF total tau (t-tau), 14-3-3, NfL, phospho-tau181 (p-tau), and amyloid-beta isoforms 42 (Aβ42) and 40 (Aβ40) in sCJD (n = 132) and non-prion RPD (np-RPD) (n = 94) patients, and healthy controls (HC) (n = 54). We also measured the CSF GFAP in 67 sCJD patients. Pl-GFAP was significantly elevated in the sCJD compared to the np-RPD and HC groups and affected by the sCJD subtype. Its diagnostic accuracy (area under the curve (AUC) 0.760) in discriminating sCJD from np-RPD was higher than the plasma and CSF NfL (AUCs of 0.596 and 0.663) but inferior to the 14-3-3, t-tau, and pl-tau (AUCs of 0.875, 0.918, and 0.805). Pl-GFAP showed no association with sCJD survival after adjusting for known prognostic factors. Additionally, pl-GFAP levels were associated with 14-3-3, pl-tau, and pl-NfL but not with CSF GFAP, Aβ42/Aβ40, and p-tau. The diagnostic and prognostic value of pl-GFAP is inferior to established neurodegeneration biomarkers. Nonetheless, pl-GFAP noninvasively detects neuroinflammation and neurodegeneration in sCJD, warranting potential applications in disease monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Creutzfeldt-Jakob SyndromeGlial Fibrillary Acidic Proteintau ProteinsBiomarkersDementiaAmyloid beta-PeptidesHumansFemaleMaleAgedMiddle AgedPrognosisNeurofilament ProteinsDisease Progression14-3-3 Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseCreutzfeldt–Jakob diseaseGFAPbiomarkerco-pathologyneurodegenerationneuroinflammationprion

Substanzen

Glial Fibrillary Acidic Proteintau ProteinsBiomarkersGFAP protein, humanAmyloid beta-PeptidesNeurofilament Proteinsneurofilament protein L14-3-3 Proteins

Autor:innen und Institutionen

  • Department of Biomedical and Neuromotor Sciences (DiBiNeM), University of Bologna, 40139 Bologna, Italy.
  • IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.

ORCID-Profile: Simone Baiardi, Sabina Capellari, Piero Parchi

Förderung

  • Ministero della Salute
  • Italian Ministero della Salute (“Ricerca Corrente”)

Zitieren

APA

Bentivenga, G. M., Baiardi, S., Mastrangelo, A., Zenesini, C., Mammana, A., Rossi, M., Polischi, B., Capellari, S., & Parchi, P. (2024). Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia. International Journal of Molecular Sciences, 25(10), 5106. https://doi.org/10.3390/ijms25105106

Vancouver

Bentivenga GM, Baiardi S, Mastrangelo A, Zenesini C, Mammana A, Rossi M, et al. Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia. International Journal of Molecular Sciences. 2024;25(10):5106. doi:10.3390/ijms25105106

BibTeX
@article{Bentivenga2024,
  author = {Bentivenga, Giuseppe Mario and Baiardi, Simone and Mastrangelo, Andrea and Zenesini, Corrado and Mammana, Angela and Rossi, Marcello and Polischi, Barbara and Capellari, Sabina and Parchi, Piero},
  title = {Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {10},
  pages = {5106},
  doi = {10.3390/ijms25105106}
}
Kostenlos starten →